Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
NP-101 by Novatek Pharmaceuticals for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
NP-101 is under clinical development by Novatek Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to...